Insights

Strategic AI Expansion Shuttle Pharmaceuticals recently announced a major advancement to its molecule.ai platform, expanding capabilities in therapeutic discovery and AI-driven drug development. This signals a potential open door to partnerships with biotech firms and CROs leveraging AI for faster candidate identification and optimization.

Radiation Therapy Focus The company targets cancer patients treated with radiation therapy and develops a sensitizer that enhances radiation efficacy, offering potential collaboration with radiation oncology centers, hospitals, and medical device/pharma collaborators seeking radiosensitizers or companion diagnostics.

Diagnostics Throughput With a mass spectrometry based diagnostics platform aimed at predicting clinical outcomes for prostate cancer radiotherapy, there are opportunities to partner with diagnostic labs, payers, and health systems interested in outcome prediction, patient stratification, and precision radiotherapy.

Strategic Fundraising Recent public offerings and capital markets activity indicate ongoing fundraising and financing needs. This presents a path for potential investment partners, strategic co-development deals, and early collaboration discussions to align on product milestones and value inflection points.

Academic and Industry Collaborations Active sponsored research agreements with UCSF for PSMA-targeted ligands and other collaborations suggest a pattern of academia-industry engagement. There is room to propose additional joint research programs, licensing discussions, or translational partnerships with cancer centers and university labs.

Similar companies to Shuttle Pharmaceuticals, Inc.

Shuttle Pharmaceuticals, Inc. Tech Stack

Shuttle Pharmaceuticals, Inc. uses 8 technology products and services including iCIMS, Wix, WordPress, and more. Explore Shuttle Pharmaceuticals, Inc.'s tech stack below.

Media & News

Shuttle Pharmaceuticals, Inc.'s Email Address Formats

Shuttle Pharmaceuticals, Inc. uses at least 2 email formats:
Shuttle Pharmaceuticals, Inc. Email FormatsExamplePercentage
First.Last@shuttlepharma.orgJohn.Doe@shuttlepharma.org
100%
FLast@shuttlepharma.comJDoe@shuttlepharma.com
100%

Frequently Asked Questions

What is Shuttle Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc.'s official website is shuttlepharma.com and has social profiles on LinkedIn.

How much revenue does Shuttle Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Shuttle Pharmaceuticals, Inc.'s annual revenue is estimated to be <$1M.

What is Shuttle Pharmaceuticals, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Shuttle Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Shuttle Pharmaceuticals, Inc. has approximately 5 employees across 2 continents, including North America and Europe. Key team members include Chief Financial Officer: T. L., Vp Regulatory: M. V. H. and Co-Founder, Board Member: M. B. Explore Shuttle Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Shuttle Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc. operates in the Biotechnology Research industry.

What technology does Shuttle Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc.'s tech stack includes iCIMS, Wix, WordPress, Google Cloud, WP Engine, Vimeo, HTTP/3 and Piwik PRO Core.

What is Shuttle Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc.'s email format typically follows the pattern of First.Last@shuttlepharma.org. Find more Shuttle Pharmaceuticals, Inc. email formats with LeadIQ.

When was Shuttle Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Shuttle Pharmaceuticals, Inc. was founded in 2012.
Shuttle Pharmaceuticals, Inc. logo

Shuttle Pharmaceuticals, Inc.

Biotechnology ResearchMaryland, United States2-10 Employees

Shuttle Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients treated with radiation therapy. Its therapeutic approach aims to sensitize cancer cells to radiation, promoting DNA damage and activating innate immune responses, with potential to combine with checkpoint inhibitors and other immune therapies. The company also operates a diagnostics business that seeks to predict clinical outcomes to guide treatment decisions for patients considering radiation therapy for prostate cancer. It is based in Rockville, Maryland, and targets clinicians and patients involved in radiation-based cancer treatment. 

The company is a small organization within the biotechnology research industry. In March 2026, Shuttle Pharmaceuticals announced a major advancement to its molecule.ai platform, signaling ongoing progress in AI-driven drug discovery.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
2-10

Section iconFunding & Financials

  • <$1M

    Shuttle Pharmaceuticals, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.